Markets hold gains; pharma stocks under pressure after Trump speech

The overall market breadth remained negative, with about 1,132 advances against 1,423 declines

Markets hold gains even as Trump speech puts pharma shares under pressure
Pranati Deva New Delhi
Last Updated : Jan 12 2017 | 1:50 PM IST
Benchmark Indices continued to rise in the after-noon trade led by IT stocks on hopes U.S. President-elect Donald Trump may not proceed with stringent visa rules.
 
Gains were capped by pharma stocks after Trump said pharmaceutical companies are "getting away with murder" in what they charge the government for medicines, and promised that would change in his first presser.
 
In a choppy trade, Nifty continued to hover around it’s 8,400 mark which it hit earlier in the day led by gains in NTPC, PowerGrid, Tata Power and L&T while Sensex continued to stay 100 points higher.
 

Also Read

At 1:20 pm, the Sensex was trading at 27,257, up 117 points, while the broader Nifty50 was ruling at 8,409, up 29 points.
 
The broader market underperformed the headline indices with BSE Midcap gaining 0.09% and BSE Smallcap losing 0.01%. 

The overall market breadth remained negative, about 1132 shares have advanced, 1423 shares declined, and 152 shares are unchanged.
 
NTPC, Power Grid, L&T, Infosys and ONGC are top gainers while Dr Reddy’s, Coal India, Lupin, and Sun Pharma are top laggards in the Sensex.
 
IT Index rose over 1% on BSE with Infosys gaining more than 2% in today’s trade ahead of it’s Q3 earnings tomorrow..
 
Nifty Pharma index fell as much as 2.24 pct, contributing to more than half the losses on the NSE index after Trump’s presser. Top losers include Cadila Healthcare, down 2.9%, Sun Pharma down, 2.96%, and Aurobindo Pharma down 3.76%. 
 
Biocon shares rallied 5% to Rs 1052 after the biotech firm and pharma firm Mylan said that the US health regulator has accepted Mylan's biologics license application (BLA) for MYL- 1401O, a proposed biosimilar trastuzumab indicated for treatment of breast cancer.
 
Shares of public sector undertaking companies (PSUs) were in focus with the S&P BSE PSU index hitting 22-month high on Thursday in intra-day trade after strong gain in electric utilities and oil & gas stocks.
 
Total 12 PSU stocks include NTPC, NHPC, Steel Authority of India (SAIL), Moil and MMTC hit their respective 52-week highs, while, Bharat Electronics, Hindustan Petroleum Corporation (HPCL), Indian Oil Corporation (IOC) and Power Grid Corporation of India hit lifetime highs on the BSE.
 
NTPC gained around 5% in afternoon trade after reports that it has signed a non-binding agreement with Rajasthan Rajya Vidyut Utpadan Nigam Ltd and Rajasthan Urja Vikas Nigam Ltd for takeover of Chhabra Thermal Power Plant.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story